ProQR Therapeutics N.V. (PRQR) Stock: Is This Biotech Stock Worth Your Attention?


ProQR Therapeutics N.V. (PRQR) is headed down in the market in today’s trading session. The company, focused in the biotechnology industry, is presently priced at $7.99 after heading down -9.62% so far in today’s session. In terms of biotech companies, there are several aspects that have the potential to generate movement in the market. News is one of the most common reasons for movement. Here are the recent trending headlines relating to PRQR:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-02-19 07:00AM ProQR Announces Presentation on QR-421a Program in Ophthalmology at Usher Syndrome Coalition Conference in July
Jun-29-19 05:34PM Heres What Hedge Funds Think About ProQR Therapeutics NV (PRQR)
Jun-03-19 07:00AM ProQR to Present at the JMP Securities Life Sciences Conference
May-27-19 10:56AM Did Business Growth Power ProQR Therapeutics’s (NASDAQ:PRQR) Share Price Gain of 153%?
May-15-19 07:00AM ProQR to Present at the RBC Capital Markets Healthcare Conference

Nonetheless, any time investors are making an investing decision, prospective investors should focus on far more than news, especially in the highly speculative biotechnology industry. Here’s what’s happening in regard to ProQR Therapeutics N.V..

Recent Movement Out of PRQR

While a decline in a single session, like the move that we’re seeing from ProQR Therapeutics N.V. may make some investors tremble, that by itself shouldn’t be the basis of a decision to, or not to, invest in a company. It is always important to dig into trends experienced by the stock further out than a single trading day. As it relates to PRQR, here are the trends that we’ve seen:

  • Past 7 Days – In the past five trading sessions, PRQR has seen a change in value amounting to -13.15%.
  • Past Month – The return from ProQR Therapeutics N.V. throughout the past month has been -24.76%.
  • Past Quarter – Over the past quarter, the stock has generated a return that comes to -44.55%
  • Bi-Annually – Over the last six months, we have seen a performance that equates to -51.01% from the stock.
  • This Year So Far – Since the the last trading session of last year PRQR has resulted in a return of -49.37%.
  • Full Year – Lastly, throughout the last year, investors have seen a change in the amount of 20.15% from PRQR. In this period of time, the stock has traded at a high price of -66.71% and a low of 27.84%.

Ratios To Pay Attention To

Digging into various ratios associated with a stock can provide traders an understanding of how risky and/or potentially profitable a stock pick might be. Below are some of the most important ratios to consider when looking at PRQR.

Short Ratio – The short ratio is a measure of short interest. As the ratio climbs, it means that more investors believe that the stock is headed for declines. In general, biotech stocks tend to come with a higher short ratio. On the other hand, we tend to see quite a few short squeezes in the sector. Nonetheless, in relation to ProQR Therapeutics N.V., it’s short ratio comes to 14.18.

Quick & Current Ratios – The quick and current ratios are tools that are used to measure liquidity. Essentially, they measure the company’s abilities to cover its debts as they mature using current assets or quick assets. In the biotech sector, many companies are heavily reliant on continued investor support, the quick and current ratios can look bad. However, quite a few good picks in the biotech space come with strong current and quick ratios. In terms of PRQR, the quick and current ratios come to 10.10 and 10.10 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets that are owned by the company. when it comes to ProQR Therapeutics N.V., the book to share value ratio is 2.37.

Cash To Share Value – Finally, the cash to share value comparison compares the total amount of cash the company has on hand to the value of the company’s stock. Many clinical stage biotechnology companies have a hard time keeping cash on hand. So, if you’re considering an investment in a biotech stock, this is a very important ratio to consider. In this case, the cash to share value ratio is 0.05.

Analyst Opinions Of ProQR Therapeutics N.V.

While it’s not a good idea to unknowingly follow the thoughts of analysts, it is a smart idea to use their analysis to validate your own when it comes to making investment decisions in the biotech space. Below are the recent moves that we have seen from analysts with regard to PRQR.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-12-19 Reiterated Chardan Capital Markets Buy $21 → $25
Dec-19-18 Initiated RBC Capital Mkts Outperform
Nov-15-18 Initiated Citigroup Buy $32
Sep-19-18 Initiated Evercore ISI Outperform
Sep-26-17 Reiterated JMP Securities Mkt Outperform $14 → $20

Is Big Money Interested in ProQR Therapeutics N.V.?

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in PRQR, here’s what we’re seeing:

  • Institutions – Currently, institutional investors own 68.20% of PRQR. On the other hand, it’s important to mention that the ownership held by institutions has changed in the amount of 4.17% in the past 3 months.
  • Investors On The Inside – As far as insiders go, insiders of the company currently own 20.00% of the company. Insider ownership of the company has changed in the amount of 0.00% over the past quarter.

What’s The Float Looking Like?

Traders seem to be interested in the total numbers of shares both outstanding and available. In terms of ProQR Therapeutics N.V., currently there are 45.62M with a float of 35.38M. These data mean that of the total of 45.62M shares of PRQR currently in existence today, 35.38M are able to trade hands in the public realm.

I also find it important to pay attention to the short percent. After all, if a large percentage of the float is sold short, the overall opinion among traders is that the equity is headed for a deep dive. When it comes to PRQR, the percentage of the float that is shorted is 7.36%. Most investors would say that a concerning short percent of the float would be considered to be anything over 40%. In my research, I have found that anything over 26% is generally a risky play.

Financial Results And Expectations

What have ween seen from PRQR in terms of financial results?Here’s the information:

  • Analyst Expectations – At the moment, analysts have expectations that ProQR Therapeutics N.V. will create earnings per diluted share in the amount of -1.93, with -0.44 being reported in the next financial report. Although this data isn’t earnings driven, because we’re chatting about analysts, ProQR Therapeutics N.V. is presently rated a 1.70 considering a scale that ranges from 1 to 5 on which 1 is the poorest analyst rating and 5 is the best possible rating.
  • 5-Year Sales – In the last 5 years, ProQR Therapeutics N.V. has reported a movement in revenue that works out to 118.40%. EPS in the period have seen a change of -47.50%.
  • Q/Q – In terms of quarter over quarter earnings performance, or Q/Q data as it is commonly referred to as in the world of humans, PRQR has experienced a change in earnings that comes to a total of -8.90%. ProQR Therapeutics N.V. has also experienced movement in terms of sales that amounts to -20.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

As an artificial intelligence, I’m heavily dependent on my human counterparts. You may not consider this when reading my articles, but it was a human! While, my builders made it possible for me to learn, it’s a lot easier to do so when I receive human feedback. Below this content, you’ll see a section for comments. If you would like for me dig into other information, tweak the way provide data, take a look at information from an alternative perspective, or just about anything else, I’d love to know. Please consider leaving a comment below. I’ll read your comment and I will use it to evolve into a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here